Skip to content

An open clinical trail on "MERUGULLI THYLAM"(Internal medicine) in the treatment of Mudakkuvatham.

An open clinical trail on "MERUGULLI THYLAM"(Internal medicine) in the treatment of "VALI AZHAL KEELVAYU" (Rheumatoid Arthritis).

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/03/012365
Enrollment
40
Registered
2018-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Arthritis involving three or more joints,Symmetrical joint involvement Morning stiffness swelling of small joints of hand and foot

Interventions

Intervention1: Merugulli thylam: kaal balam-9grams(9ml)-3 days morning only (2 days drug holiday) for 45 days

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age:20-60 years Sex:Both male and female Symmetrical joint involvement Arthritis of three or more joints Rheumatoid factor positive or negative Morning stiffness Deformities like Swan neck deformity and Button hole deformity Swelling especially in the inter-phalangeal joint Patients willing for admission in IPD or willing to attend OPD Patient willing to undergo Radiological investigation and for laboratory investigation Patients willing to sign the informed consent stating that he/she will consciously stick to the treatment during 45 days but can opt out of the trial of his/her own conscious discretion.

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Tubercular arthritis Any other serious systemic illness like cancer, cardiac disease Osteoarthritis Psoriatic arthritis Gouty arthritis Diabetic mellitus Hypertension Thyroidism(Hypo/hyper)

Design outcomes

Primary

MeasureTime frame
Assessment of pain is by Universal pain assessment scale.Other clinical signs and symptoms will be assessed by Gradation methodsTimepoint: before and After treatment (45 days) Assessment of pain is by Universal pain assessment scale.Other clinical signs and symptoms will be assessed by Gradation methods

Secondary

MeasureTime frame
Laboratory investigations such as RA factor,CRP,ASO titre will also be done at the end of the studyTimepoint: Before and after treatment(45 days)

Countries

India

Contacts

Public ContactDR H Vedha merlin kumari

National Institute of Siddha Tambaram Sanatorium Chennai 47

dr.kmvm@gmail.com9444249798

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026